Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue
- 3 March 1998
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 52 (1-2), 205-213
- https://doi.org/10.1016/s0168-3659(97)00216-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Enhancement of the mechanical properties of polylactides by solid-state extrusion: I. Poly(d-lactide)Biomaterials, 1996
- In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polylactide particlesBiomaterials, 1995
- Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigationJournal of Controlled Release, 1995
- A mechanistic study of antibiotic release from biodegradable poly(d,1-lactide) cylindersJournal of Controlled Release, 1994
- Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cellsEndocrinology, 1994
- Effect of somatostatin analog RC‐160 and bombesin/gastrin releasing peptide antagonist RC‐3095 on growth of PC‐3 human prostate‐cancer xenografts in nude miceInternational Journal of Cancer, 1993
- Physico-mechanical properties of degradable polymers used in medical applications: A comparative studyBiomaterials, 1991
- In vivo characteristics of low molecular weight copoly(D,L-lactic acid) formulations with controlled release of LH-RH agonistBiomaterials, 1989
- Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Amorphous and crystalline morphologies in glycolic acid and lactic acid polymersPolymer, 1987